Labema Group is a Finland-based organization that has been pioneering in the biotechnology industry since its establishment in 1988. The company specializes in importing, promoting, and delivering top-notch diagnostic equipment and supplies to various sectors including healthcare, food industry, and research laboratories. Its expertise primarily lies in Microbiology, Molecular biology, Food diagnostics, and Drug of Abuse diagnostics. What sets Labema apart is its emphasis on understanding and foreseeing the ever-evolving needs of its customers, which is achieved through continuous market assessment and close collaboration with both customers and suppliers. By maintaining a strong focus on scientific and practical proficiency in diagnostic systems and processes, Labema has secured its position as an expert in the field. Thus far, the company has not disclosed any latest investment details or associated investors. However, Labema's proactive approach in adapting to market demands and forming strategic partnerships positions it as an intriguing prospect for potential investors seeking exposure to the burgeoning biotechnology sector.
There is no investment information
No recent news or press coverage available for Labema Group.
We care about your data, and we'd love to use cookies make your experience better.
